Embody GLP-1 Review 2026: The Oral Tirzepatide Option Worth Knowing About

Reviewed by RC Nelson, Health & Wellness Writer. Last updated April 2026.

Key Takeaways

• $149 first month includes medication, metabolic report, and personalized plan
• Ongoing refills locked at $299/mo regardless of dose
• Unique oral tirzepatide gum for patients who dislike needles
• Compounded semaglutide (injectable) also available
• 24/7 specialist support and 1:1 guidance included
• Available in all 50 states
• No insurance accepted

What Is Embody?

Embody is a telehealth platform that prescribes compounded GLP-1 medications for weight loss. What makes them interesting is two things: a legitimately low first-month price, and an oral tirzepatide option that most competitors do not offer.

The oral tirzepatide comes as a dissolvable gum. It contains the same active ingredient as Mounjaro and Zepbound, just delivered without a needle. If you have been avoiding GLP-1 treatment because you cannot stand injections, this is one of the few platforms where that is not a dealbreaker. (Note: oral compounded formulations may absorb differently than injectables. Your provider can help you decide which format makes sense for your situation.)

They also include a metabolic report with your first month, which gives you a baseline on where your body is at before treatment starts. That is a nice touch at the $149 price point, since most competitors charging similar rates give you medication and not much else.

Pricing Breakdown

Here is the thing you need to know about Embody: that first month is a hook. $149 is genuinely cheap for a GLP-1 program that includes a metabolic report, personalized plan, and medication. But the jump to $299/mo for ongoing treatment puts Embody above most of its competitors.

For context:

If you are budget-sensitive beyond the first month, GobyMeds at $99/mo or Henry Meds starting at $149/mo will save you real money over time. But neither of those offers the oral option.

How It Works

1. Complete an online health questionnaire. Standard intake covering your weight, medical history, current medications, and goals.
2. Provider review. A state-licensed provider reviews your information. This is async, so no video call needed.
3. Medication ships with your plan. You get your medication, a personalized treatment plan, and your metabolic report delivered to your door. Shipping is free.
4. Ongoing support. You have access to 1:1 guidance and 24/7 specialist support throughout your treatment.

Medications

Compounded Semaglutide (injectable) is the standard option. Same active ingredient as Ozempic and Wegovy, prepared by a compounding pharmacy.

Compounded Tirzepatide (oral gum) is the differentiator. This is a dissolvable gum containing the same dual-action GLP-1/GIP ingredient as Mounjaro and Zepbound. For patients who are genuinely needle-phobic, this matters. Most GLP-1 providers only offer injectables, which means a lot of people who could benefit from treatment never start because they cannot handle the needle.

Both are compounded, not brand-name. If you specifically need FDA-approved Wegovy or Zepbound, Embody is not the right fit. Look at Eden or Ro instead.

Pros

The first month is a real deal. $149 for medication, a metabolic report, a personalized plan, and specialist access is hard to beat. Even if you end up switching providers later, it is a low-risk way to start GLP-1 treatment.

Oral tirzepatide is rare. Very few platforms offer a non-injectable GLP-1 option. If needles are your barrier, Embody solves that problem. (Strut Health also offers an oral semaglutide lozenge if you prefer semaglutide specifically.)

Metabolic report included. Getting a baseline metabolic analysis at the intro price is a nice bonus that most budget providers skip.

All 50 states. No coverage gaps. You can start treatment regardless of where you live.

Cons

$299/mo ongoing is steep. After the first month, you are paying more than Hims ($199/mo), Henry Meds ($149/mo), or GobyMeds ($99/mo) for what is still compounded medication. That is the elephant in the room.

Compounded only. No brand-name Wegovy, Ozempic, or Zepbound. If you want FDA-approved medications, look elsewhere.

Newer platform. Embody does not have the track record of a Hims or Ro. That is not necessarily a red flag, but it is worth noting.

Embody vs. the Competition

Who Is Embody Best For?

Embody makes the most sense for two types of patients:

1. Needle-averse patients who want GLP-1 treatment but cannot handle injections. The oral tirzepatide gum is a genuine differentiator that very few competitors offer.

2. First-time GLP-1 users who want a low-risk entry point. The $149 first month with a metabolic report is a solid way to test whether GLP-1 treatment works for you before committing to a higher monthly cost.

It is not the best fit if ongoing cost is your primary concern. At $299/mo, you can find comparable compounded medications for significantly less.

The Bottom Line

Embody's strength is the oral tirzepatide gum, full stop. If needles are your dealbreaker, this is one of the only platforms that removes that barrier. The $149 first month is a genuinely good deal, and the included metabolic report adds real value at that price point.

The $299/mo ongoing cost is where it gets harder to recommend over cheaper alternatives. If you are comfortable with injections and price-sensitive, GobyMeds or Henry Meds will save you $100-200/mo for similar compounded medications.

But for the needle-averse crowd? Embody fills a gap that most of the market ignores.

Considering Embody? Check your eligibility on their site and see what plan fits your needs.

---

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.